Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Alnylam Pharmaceuticals Inc Stock News

ALNYNASDAQ

Trade with Public

Trade with Public

$286.98

-6.47-2.20%

At close: May 15, 5:00 PM EST

$289.00

2.020.70%

After Hours: 6:16 PM EST

OverviewNewsEarnings Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Latest Alnylam Pharmaceuticals Stock News | NASDAQ:ALNY | Benzinga

Get the latest news on Alnylam Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Alnylam Pharmaceuticals performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, May 12, 2026

PRO
Alnylam Presents HELIOS-B Data At Heart Failu...
Benzinga Newsdesk

Tuesday, May 05, 2026

PRO
HC Wainwright & Co. Reiterates Buy on Alnylam...
Benzinga Newsdesk

Friday, May 01, 2026

PRO
RBC Capital Maintains Outperform on Alnylam P...
Benzinga Newsdesk
PRO
Wells Fargo Maintains Equal-Weight on Alnylam...
Benzinga Newsdesk

Thursday, April 30, 2026

PRO
Alnylam Pharmaceuticals Affirms FY2026 Sales ...
Benzinga Newsdesk
PRO
Alnylam Pharmaceuticals Q1 Adj. EPS $1.99 Bea...
Benzinga Newsdesk
Earnings Scheduled For April 30, 2026
Benzinga Insights

Tuesday, April 21, 2026

Here's How Much $1000 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth Today
Benzinga Insights

Monday, April 13, 2026

PRO
Truist Securities Maintains Buy on Alnylam Ph...
Benzinga Newsdesk

Tuesday, April 07, 2026

Mach Natural Resources, Mesoblast And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor

Thursday, April 02, 2026

PRO
Alnylam Pharmaceuticals shares are trading lo...
Benzinga Newsdesk

Monday, March 30, 2026

PRO
Alnylam Presents New Clinical, Real-World Dat...
Benzinga Newsdesk

Wednesday, March 25, 2026

10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
PRO
HC Wainwright & Co. Reiterates Buy on Alnylam...
Benzinga Newsdesk

Tuesday, March 24, 2026

PRO
Alnylam Pharmaceuticals Advancing Approach To...
Benzinga Newsdesk

Tuesday, March 17, 2026

Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 20 Years
Benzinga Insights

Monday, March 16, 2026

PRO
Jefferies Downgrades Alnylam Pharmaceuticals ...
Benzinga Newsdesk

Tuesday, March 10, 2026

BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz
Vandana Singh

Thursday, March 05, 2026

Tenaya Therapeutics Stock Jumps After New Alnylam Deal
Vandana Singh
PRO
Tenaya Therapeutics Collaborates With Alnylam...
Benzinga Newsdesk

Monday, March 02, 2026

PRO
Alnylam Canada ULC Wins CDA Reimbursement Rec...
Benzinga Newsdesk

Monday, February 23, 2026

Here's How Much $100 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today
Benzinga Insights

Wednesday, February 18, 2026

PRO
HC Wainwright & Co. Reiterates Buy on Alnylam...
Benzinga Newsdesk
Insider Unloading: Jeffrey V Poulton Sells $695K Worth Of Alnylam Pharmaceuticals Shares
Benzinga Insights
EVP Of Alnylam Pharmaceuticals Makes $607K Sale
Benzinga Insights
Sell Alert: Yvonne Greenstreet Cashes Out $2.16M In Alnylam Pharmaceuticals Stock
Benzinga Insights

Tuesday, February 17, 2026

PRO
Alnylam Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
PRO
Freedom Capital Markets Upgrades Alnylam Phar...
Benzinga Newsdesk
PRO
Canaccord Genuity Maintains Buy on Alnylam Ph...
Benzinga Newsdesk

Friday, February 13, 2026

Demystifying Alnylam Pharmaceuticals: Insights From 13 Analyst Reviews
Benzinga Insights
PRO
Chardan Capital Maintains Buy on Alnylam Phar...
Benzinga Newsdesk

Thursday, February 12, 2026

PRO
Needham Maintains Buy on Alnylam Pharmaceutic...
Benzinga Newsdesk
PRO
Alnylam Pharmaceuticals Sees FY2026 Sales $5....
Benzinga Newsdesk
Alnylam Pharmaceuticals Q4 Earnings Assessment
Benzinga Insights
PRO
Alnylam Pharmaceuticals Q4 Adj. EPS $1.25 Bea...
Benzinga Newsdesk
Earnings Scheduled For February 12, 2026
Benzinga Insights

Wednesday, February 11, 2026

An Overview of Alnylam Pharmaceuticals's Earnings
Benzinga Insights

Friday, January 30, 2026

PRO
Morgan Stanley Maintains Equal-Weight on Alny...
Benzinga Newsdesk
PRO
B of A Securities Maintains Buy on Alnylam Ph...
Benzinga Newsdesk
PRO
HC Wainwright & Co. Maintains Buy on Alnylam ...
Benzinga Newsdesk

Wednesday, January 28, 2026

11 Analysts Have This To Say About Alnylam Pharmaceuticals
Benzinga Insights

Tuesday, January 20, 2026

PRO
RBC Capital Maintains Outperform on Alnylam P...
Benzinga Newsdesk
PRO
Wells Fargo Maintains Equal-Weight on Alnylam...
Benzinga Newsdesk

Thursday, January 15, 2026

A Look Into Alnylam Pharmaceuticals Inc's Price Over Earnings
Benzinga Insights
EVP Of Alnylam Pharmaceuticals Sold $547K In Stock
Benzinga Insights
Insider Selling: Jeffrey V Poulton Unloads $1.01M Of Alnylam Pharmaceuticals Stock
Benzinga Insights
Alnylam Pharmaceuticals Chief Executive Officer Sold $3.48M In Company Stock
Benzinga Insights

Monday, January 12, 2026

Alnylam Lays Out 2030 Vision, Bets On TTR Leadership And Pipeline Scale
Vandana Singh
Gold, Silver Spike To Record Highs As Fed Independence Falters: What's Moving Markets Monday?
Piero Cingari
PRO
B of A Securities Maintains Buy on Alnylam Ph...
Benzinga Newsdesk

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved